CPAx: Responsiveness and Minimal Clinically Important Difference — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

CPAx: Responsiveness and Minimal Clinically Important Difference — Stella

Recruiting

Back to Muscle Weakness trials

Trial locations(3 sites)

Australia

Monash Health, Clayton

Alfred Health, Melbourne

Switzerland

Inselspital, Bern

Key details

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators

Monash University

Enrollment target

~120 participants

Started

May 2024

Primary completion

October 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated October 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov